Literature DB >> 2076407

Early regression of left ventricular diastolic abnormalities in hypertensive patients treated with nifedipine.

I Sheiban1, G Covi, C Zenorini, G Arcaro, E Arosio, S Tonni, G Montresor, A Lechi.   

Abstract

The effects of nifedipine on blood pressure (BP), left ventricular hypertrophy, and diastolic function were evaluated in 14 patients with essential hypertension (EH). All males with a mean age of 44 +/- 6 years (range 35-58 years), and in ten normotensive subjects (control group) aged 32-42 years (mean age 36 +/- 4). A complete echocardiogram (ECHO) was performed in basal conditions after 1 and 6 months of therapy with nifedipine (20-40 mg/day). Left ventricular echocardiograms (LV ECHO, M-mode, two-dimensional guided) were plotted with a simultaneous ECG tracing by means of a computerized system that allows evaluation of the following parameters: LV end-diastolic and systolic diameters (EDD, ESD); variations in LV diameter and volume during the entire cardiac cycle, and the velocities of such variations; end-diastolic thicknesses of the interventricular septum and posterior wall (ST, PWT); LV mass, mass/volume (M/V) index, end-diastolic diameter/thickness (D/Th) index, and LV ejection fraction (EF). Left ventricular volume curves were obtained and the contributions of rapid filling (RF) and atrial systole (AS) to EDV were evaluated. Filling velocities during RF (vRF) and AS (vAS) were estimated, as well as the isovolumic relaxation period (IR). No significant changes were observed in the heart rate. After 1 month of therapy, systolic and diastolic BP were significantly decreased (p less than 0.05). ST and PWT were reduced, with a simultaneous increase in EDD and EDV (p less than 0.01). LV mass was slightly reduced, as was the M/V index. The D/Th index was increased (p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076407     DOI: 10.1007/BF02018300

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  21 in total

Review 1.  Left ventricular compliance: mechanisms and clinical implications.

Authors:  W H Gaasch; H J Levine; M A Quinones; J K Alexander
Journal:  Am J Cardiol       Date:  1976-11-04       Impact factor: 2.778

2.  Left ventricular mass and function before and after antihypertensive treatment.

Authors:  M Lombardo; G Zaini; F Pastori; M Fusco; S Pacini; C Foppoli
Journal:  J Hypertens       Date:  1983-10       Impact factor: 4.844

Review 3.  Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy.

Authors:  I Ostman-Smith
Journal:  Clin Sci (Lond)       Date:  1981-09       Impact factor: 6.124

4.  Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study.

Authors:  P Hanrath; D G Mathey; R Siegert; W Bleifeld
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

5.  Changes in left ventricular mass during a double-blind study with chlorthalidone and slow-release nifedipine.

Authors:  L A Ferrara; G de Simone; M Mancini; M L Fasano; F Pasanisi; G Vallone
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Regression of left ventricular hypertrophy during treatment with antihypertensive agents.

Authors:  L S Hill; M Monaghan; P J Richardson
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

7.  Diastolic function of the heart in untreated primary hypertension.

Authors:  M Hartford; J Wikstrand; I Wallentin; S Ljungman; L Wilhelmsen; G Berglund
Journal:  Hypertension       Date:  1984 May-Jun       Impact factor: 10.190

8.  Doppler echocardiographic analysis of left ventricular filling in treated hypertensive patients.

Authors:  R A Phillips; N L Coplan; L R Krakoff; K Yeager; R S Ross; R Gorlin; M E Goldman
Journal:  J Am Coll Cardiol       Date:  1987-02       Impact factor: 24.094

9.  Echocardiographic assessment by computer-assisted analysis of diastolic left ventricular function and hypertrophy in borderline or mild systemic hypertension.

Authors:  V Papademetriou; J S Gottdiener; R D Fletcher; E D Freis
Journal:  Am J Cardiol       Date:  1985-09-15       Impact factor: 2.778

10.  Echocardiographic features of malignant hypertension.

Authors:  L M Shapiro; J Mackinnon; D G Beevers
Journal:  Br Heart J       Date:  1981-10
View more
  1 in total

1.  Left ventricular diastolic function during adrenergic stress in essential hypertension: acute and chronic effects of ACE inhibition.

Authors:  G Covi; I Sheiban; G Gelmini; G Arcaro; S Tonni; A Bolner; G Piemonte; A Lechi
Journal:  Cardiovasc Drugs Ther       Date:  1996-07       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.